NCT02248636 - Cholinesterase Inhibitor Discontinuation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 22, 2015

Primary Completion Date

October 1, 2019

Study Completion Date

October 1, 2019

Conditions

Dementia

Interventions

DRUG

Cholinesterase inhibitor

This group receives a half-dose of their previous cholinesterase inhibitor medication (in overencapsulated form) for two weeks, then receives placebo.

DRUG

Sham discontinuation

This group receives their previous dose of cholinesterase inhibitor medication, but in overencapsulated form

Trial Locations (4)

83702

Boise VA Medical Center, Boise, ID, Boise

98108

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

72205-5484

Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR, Little Rock

01730

Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, Bedford

All Listed Sponsors

lead

VA Office of Research and Development

FED